LeoNovus (FRA:LE4A) Research & Development: €0.00 Mil (TTM As of Mar. 2026)


FRA:LE4A LeoNovus Inc FRA:LE4A
14 GF Score
Price €0.02
GF Value €0.07
View Full Analysis

What is LeoNovus Research & Development?

LeoNovus FRA:LE4A 14 Research & Development is €0.00 Mil as of Mar. 2026. GuruFocus rates FRA:LE4A with a GF Score™ of 14/100 and a GF Value™ of €0.07.

Research & Development is the aggregate amount of research and development expenses during the year. LeoNovus's Research & Development for the three months ended in Mar. 2026 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €0.00 Mil.


LeoNovus  (FRA:LE4A) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


LeoNovus Research & Development Related Terms


LeoNovus Research & Development Historical Data

* Premium members only.

The historical data trend for LeoNovus's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LeoNovus Research & Development Chart

LeoNovus Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.52 0.40 0.04 0.00 0.00

LeoNovus Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:LE4A
14GF Score
LeoNovus Inc FRA:LE4A
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LeoNovus Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.00 Mil mean?
LeoNovus (FRA:LE4A) has a Research & Development of €0.00 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on LeoNovus and its competitors.
Is LeoNovus' Research & Development too high?
LeoNovus' current Research & Development is €0.00 Mil. Overall, LeoNovus has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does LeoNovus' Research & Development compare to CRM and INTU?
LeoNovus' Research & Development of €0.00 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Software company?
A good Research & Development depends on the Software industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on LeoNovus and its competitors. LeoNovus's current Research & Development is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LeoNovus stock overvalued right now?
LeoNovus (FRA:LE4A) has a current Research & Development of €0.00 Mil. The stock's GF Value™ is €0.07, compared to a current price of €0.02 — trading 74.3% below its estimated fair value. The current Research & Development is €0.00 Mil. LeoNovus' overall GF Score™ is 14/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For LeoNovus (FRA:LE4A), the current Research & Development is €0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is LeoNovus (FRA:LE4A) Overvalued in 2026?

Based on GuruFocus' analysis, LeoNovus stock appears to be undervalued. The current stock price of €0.02 is trading 74.3% below its estimated GF Value™ of €0.07.

Key valuation signals for FRA:LE4A:

  • Research & Development: €0.00 Mil
  • GF Value™: €0.07 vs. price of €0.02 (74.3% below fair value)
  • GF Score™: 14/100

No single metric tells the full story. See the FRA:LE4A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


LeoNovus Business Description

Address 2611 Queensview Drive, Suite 125, Ottawa, ON, CAN, K2B 8K2
LeoNovus Inc s is a secure data management software company. The Leonovus suite of data management tools offers customers a complete end-to-end data-centric solution. This solution can stand on its own, or it can be integrated with the organization's zero-trust plan and architecture. It takes seamless advantage of the organization's existing storage infrastructure and network architecture, working on-premises, in the cloud, or both, and extends the data-centric controls across the entire architecture, including cloud resources.
14GF Score

Get the complete analysis for FRA:LE4A

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.02
Price
€0.07
GF Value